Experienced in Lymphedema

Nathalie Levasseur

600 West 10th Avenue, 4th Floor, 
Vancouver, BC, CA 
Experienced in Lymphedema
600 West 10th Avenue, 4th Floor, 
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Nathalie Levasseur practices in Vancouver, Canada. Ms. Levasseur is rated as an Experienced expert by MediFind in the treatment of Lymphedema. Her top areas of expertise are Breast Cancer, Milroy Disease, Lymphedema, Tissue Biopsy, and Mastectomy.

Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Lymphedema.

Gender
Female

Locations

600 West 10th Avenue, 4th Floor, Vancouver, BC V5Z4E6, Canada
Other Locations
Mount Sinai Hospital
Toronto, ON M5G1X5, Canada
BC, Canada
Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

LA LEAST- Luminal A, Limited Endocrine Adjuvant Systemic Therapy. A Trial of Abbreviated Hormone Therapy for Low Risk Hormone Receptor Positive, HER2 Negative Early Breast Cancer
LA LEAST- Luminal A, Limited Endocrine Adjuvant Systemic Therapy. A Trial of Abbreviated Hormone Therapy for Low Risk Hormone Receptor Positive, HER2 Negative Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2023
Intervention Type: Drug
Study Drug: Tamoxifen Citrate
Study Phase: Phase 2

39 Total Publications

Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: July 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Levasseur's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile